Markus Schwertfeger is Senior Director Medical Affairs at Roche Diagnostics. He has over 20 years of experience in biopharmaceutical and the medtech industry working in various local, regional, and global Medical Affairs roles.
He led teams who launched innovative drugs and managed drug portfolios in various disease areas (cardiovascular, thrombosis, diabetes, metabolism, lipids, neurology, pain, bone, sepsis, oncology) during which time he contributed to shaping activities in clinical development, regulatory framework, pharmacovigilance, and market access.
Before Markus joined the industry he gained clinical experience as a resident in internal medicine in Berlin, Germany and worked as a post-doc at the Institute of Pharmacology and Toxicology of the University of Jena, Germany where his research focus was renal and cardiovascular pharmacology and toxicology.
Markus, a medical doctor, graduated and accomplished a doctoral thesis in pharmacology and toxicology at the Friedrich Schiller University Jena, Germany.